Latest AI and machine learning research in oncology/hematology for healthcare professionals.
RATIONALE AND OBJECTIVES: Preoperative differentiation between follicular thyroid carcinoma (FTC) and follicular thyroid adenoma (FTA) remains challenging due to overlapping cytological and ultrasonographic features. This study aimed to develop and validate a multimodal deep learning model integrating ultrasound images, fine-needle aspiration cytology (FNAC) images, and clinical features for preop...
BACKGROUND: Osteosarcoma (OS) is an aggressive bone malignancy with a poor prognosis. Dysregulated calcium homeostasis may contribute to OS progression. METHODS: Various machine learning algorithms were integrated into multiple model combinations to identify key prognostic genes. Single-cell expression profiling was conducted to assess STC2 expression across different cell types within the OS micr...
Accurate neoantigen prediction is central to the design of personalized cancer immunotherapy. The immune recognition of neoantigens is a multi-step pr...
RATIONALE AND OBJECTIVES: Nasopharyngeal carcinoma (NPC) is characterized by a distinctive virologic and immunologic profile, in which Epstein-Barr vi...
The use of multimodal data is essential for the precise diagnosis and treatment of brain tumors. In this context, multimodal data encompass multiseque...
Accurate histopathological classification of renal cell carcinoma (RCC), along with its distinction from benign mimickers, is essential for precision ...
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common types of cancer globally. However, HCC features poor prognosis due to complex pat...
BACKGROUND: Breast cancer metastasis remains a major clinical challenge due to its complex molecular mechanisms, highlighting the need to identify key...
Glycans are complex carbohydrates that are integral to cancer progression and tumor biology. Conventional methods face challenges due to the structura...
BACKGROUND: Prognostic information is essential for decision-making in breast cancer management. In recent years, trials and clinical practice have em...
We present a large whole-body and total-body curated dataset of dual-modality 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-Positron Emission Tomography/Compu...
Artificial intelligence (AI) offers a powerful means to accelerate precision oncology by individualizing care in an era of rapidly evolving treatment ...
Precise survival risk stratification for bladder urothelial carcinoma (BUC) remains a clinical challenge. We developed and validated a multimodal AI a...
The FUCCI sensor fluorescently labels cell cycle phases, which is essential to assess normal and abnormal cell-cycle progression in physiological and ...
BACKGROUND: Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for rapid, accurate, and affordabl...
OBJECTIVE: The increasing global demand to assess pediatric skeletal malocclusions poses a growing challenge, as current screening methods are depende...
OBJECTIVE: To understand whether cancer-neutral image attributes (breast area and number of slices) impact an AI algorithm assessment of negative digi...
Abnormal glycolysis is one of the hallmarks of cancer and plays a significant role in its progression. This study investigates the association between...
PURPOSE: In this prospective cross-over study, the precision of manual correction of the clinical target volume (CTV) during online-adaptive radiother...
BACKGROUND: Accurate prediction of early recurrence (ER) after radical resection remains a critical challenge in pancreatic ductal adenocarcinoma (PDA...